Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Phillip Stoup

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, corporate, life sciences capital markets
Office
Bay Area
Active in the record
2020 to 2024

Deal experience

Deal types
Capital Markets & IPOM&A
Sectors
Consumer & RetailHealthcare & Life SciencesTechnology
Jurisdictions
United States

Recent deals

14 announced deals in the record
Latham & Watkins Advises Allogene Therapeutics in Pricing of US$110 Million Offering of Common Stock 17 May 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 110m capital markets Bay Area
Latham & Watkins Advises Coherus BioSciences in Divestment of Ophthalmology Franchise to Sandoz 22 Jan 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 170m Lead capital markets Bay Area
Latham & Watkins Advises Nevro Corp. on Acquisition of Vyrsa™ Technologies and Secured Financing Deal from Braidwell 9 Dec 2023
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 40m corporate
Latham & Watkins Advises CARGO Therapeutics on Pricing of Initial Public Offering 15 Nov 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 281m corporate Bay Area
Latham & Watkins Advises on Alpine Immune Sciences’ Pricing of US$150 Million Public Offering 8 Nov 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead corporate Bay Area
Latham & Watkins Advises Coherus in Pricing of Public Offering of Common Stock 23 May 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 4.25 Lead corporate Bay Area
Latham & Watkins Advises on 4D Molecular Therapeutics’ Pricing of Upsized Public Offering of Common Stock 6 May 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 120m Lead corporate Bay Area
Latham & Watkins Advises on BridgeBio Pharma’s Public Offering of Common Stock 11 Mar 2023
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Lead capital markets Bay Area
Latham & Watkins Advises Obagi on US$1.2 Billion Business Combination with Waldencast and Milk Makeup as a First Step in Waldencast’s Strategy to Create a Global Multi-Brand Beauty and Wellness Platform 15 Nov 2021
M&A Consumer & Retail Latham & Watkins LLP USD 1.20bn capital markets Bay Area
Latham & Watkins Advises the Underwriters in Eliem Therapeutics’ Initial Public Offering 10 Aug 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 80m Lead capital markets Bay Area
Deal alerts PRO

Get an email when Phillip Stoup is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

See all 14 deals for Phillip Stoup

This page shows the 10 most recent. The paid plans open the complete history for this lawyer, with full filtering, plus:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction